**Key Points:**
Netflix, Uber Technologies, and Novo Nordisk have faced significant stock price declines over the past year, each down between 17% to 18%. Netflix, currently trading at approximately $78, has shown a 28% potential upside needed to reach $100, while Uber’s shares, priced around $76, have generated over $55 billion in revenue with a P/E ratio of 17. Novo Nordisk is trading at about $47, presenting a low P/E of 11, indicating it may be undervalued despite competition in the GLP-1 drug market.
Investors consider these stocks attractive due to their potential for long-term growth, particularly at current lower valuations. Netflix continues to diversify its offerings, while Uber is expanding into international markets and the robotaxi industry. Novo Nordisk still possesses promising assets and could rebound in the market despite recent challenges.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
